Skip Navigation

Cardiovascular Research 2004 63(4):582-592; doi:10.1016/j.cardiores.2004.05.001
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Basta, G.
Right arrow Articles by De Caterina, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basta, G.
Right arrow Articles by De Caterina, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes

Giuseppina Bastaa, Ann Marie Schmidtb and Raffaele De Caterina*,a,c

aCNR Institute of Clinical Physiology, Pisa, Italy
bColumbia University, New York, NY, USA
cInstitute of Cardiology and Center for Excellence on Aging, "G. d'Annunzio" University, c/o Ospedale S. Camillo de Lellis, Via Forlanini, 50, I-66100 Chieti, Italy

* Corresponding author. Tel.: +39-0871-41512; fax: +39-0871-402817. Email address: rdecater{at}unich.it

The formation of advanced glycation end products (AGEs) is an important biochemical abnormality that accompanies diabetes mellitus and, likely, inflammation in general. Here we summarize and discuss recent studies indicating that the effects of AGEs on vessel wall homeostasis may account for the rapidly progressive atherosclerosis associated with diabetes mellitus. Driven by hyperglycemia and oxidant stress, AGEs form to a greatly accelerated degree in diabetes. Within the vessel wall, collagen-linked AGEs may "trap" plasma proteins, quench nitric oxide (NO) activity and interact with specific receptors to modulate a large number of cellular properties. On plasma low density lipoproteins (LDL), AGEs initiate oxidative reactions that promote the formation of oxidized LDL. Interaction of AGEs with endothelial cells as well as with other cells accumulating within the atherosclerotic plaque, such as mononuclear phagocytes and smooth muscle cells (SMCs), provides a mechanism to augment vascular dysfunction. Specifically, the interaction of AGEs with vessel wall components increases vascular permeability, the expression of procoagulant activity and the generation of reactive oxygen species (ROS), resulting in increased endothelial expression of endothelial leukocyte adhesion molecules. AGEs potently modulate initiating steps in atherogenesis involving blood-vessel wall interactions, triggering an inflammatory-proliferative process and, furthermore, critically contribute to propagation of inflammation and vascular perturbation in established disease. Thus, a better understanding of the biochemical mechanisms by which AGEs contribute to such processes in the vessel wall could be relevant to devise preventive and therapeutic strategies for diabetic atherosclerosis.

KEYWORDS Advanced glycation end products; Atherosclerosis; Inflammation; Diabetes; Endothelium


Time for primary review 16 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
M. Wu, Y. Chen, K. Wilson, A. Chirindel, M. A. Ihnat, Y. Yu, M. E. Boulton, L. I. Szweda, J.-X. Ma, and T. J. Lyons
Intraretinal Leakage and Oxidation of LDL in Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2679 - 2685.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A W van Deutekom, H W M Niessen, C G Schalkwijk, R J Heine, and S Simsek
Increased N{epsilon}-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus
Eur. J. Endocrinol., May 1, 2008; 158(5): 655 - 660.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-J. Choi, H.-S. Lim, J.-S. Choi, S.-Y. Shin, J.-Y. Bae, S.-W. Kang, I.-J. Kang, and Y.-H. Kang
Blockade of Chronic High Glucose-Induced Endothelial Apoptosis by Sasa borealis Bamboo Extract
Experimental Biology and Medicine, May 1, 2008; 233(5): 580 - 591.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
R. P Raghavan, D. W Laight, K. M Shaw, and M. H Cummings
Review: Aspirin and diabetes
The British Journal of Diabetes & Vascular Disease, March 1, 2006; 6(2): 74 - 82.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.